Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06020703 · ClinicalTrials.gov registry record · NA
A Study of Healthy Microbiome, Healthy Mind
A NA study of COVID-19 and Cognitive Impairment, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06020703: Recruiting NA study of COVID-19 and Cognitive Impairment, sponsored by Mayo Clinic.
NCT06020703 is a NA study of COVID-19 and Cognitive Impairment that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06020703, a NA study of COVID-19 and Cognitive Impairment, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are doing this study to find out if a high fermented food diet is tolerable, and if it will help improve quality of life after surviving a critical illness, including severe COVID-19, by promoting gut health recovery and decreasing gut inflammation.
Primary Outcome
20 critical illness survivors assigned to the intervention arm will tolerate high fermented food diet on 75% of the study days or more
Conditions Studied
Interventions
- BEHAVIORAL Fermented Food Diet
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06020703 shows while recruiting
NCT06020703 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).
The record links to 7 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Fermented Food Diet is the first listed.
NCT06020703 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06020703 about?
NCT06020703 is a clinical study titled "A Study of Healthy Microbiome, Healthy Mind". Researchers are doing this study to find out if a high fermented food diet is tolerable, and if it will help improve quality of life after surviving a critical illness, including severe COVID-19, by promoting gut health recovery and decreasing gut inflammation.
What is the current status of trial NCT06020703?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-02-26. Estimated completion is 2026-12.
What conditions does trial NCT06020703 study?
This clinical trial studies the following conditions: COVID-19, Cognitive Impairment, Critical Illness, Dysbiosis, Weakness, Muscle.
What interventions are being tested in trial NCT06020703?
The interventions under investigation include: Fermented Food Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT06020703?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06020703 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06020703's enrollment target sits among peer trials
40 257th of 298 higher than 40 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI